Penn Medicine Provider
Rheumatology
Alexis R. Ogdie, MD, MSCE
4.9
(195)
Accepting new patients
Sees patients age 18 and up
Penn Rheumatology Perelman

About me

  • Associate Professor of Medicine (Rheumatology) at the Hospital of the University of Pennsylvania
  • Associate Professor of Epidemiology in Biostatistics and Epidemiology

Education and training

  • Medical School: Georgetown University School of Medicine
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.9

195 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
the doctor has helped me so much and i have already recommended her to people.
May 2025
5.0
5.0
dr ogdie is very efficient in her inquiry of questions and respectful.
May 2025
5.0
5.0
was able to understand her explenations
May 2025
5.0
5.0
dr. ogdie is the best doctor i've ever had. she is extremely knowledgeable about everything, she is thorough and explains everything to me, and includes me in all decisions. she's compassionate, and makes me feel better.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Ogdie is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Allenzara A, Bush K, Husni ME, Reddy SM, Scher JU, Craig E, Koplin J, Walsh JA, Ogdie A. Diverse Treatment Goals in Psoriatic Arthritis: Insights from participants in the PARC cohort , Arthritis Care Res (Hoboken): 2025


Ogdie A, Reddy SM, Gillespie SH, Husni ME, Scher JU, Salomon-Escoto K, Kay J, Luedders BA, Curtis JR, Shields AJS, Chakravarty SD, Gong C, Walsh JA. Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial , Trials, 26: 2025,96


Perez-Chada LM, Gondo G, Grant C, Woodbury M, Kucharik AH, Armstrong AW, Eder L, Mease P, Ogdie A, Strand V, Gottlieb AB, Merola JF. Construct validity of the IDEOM MSK Questionnaire (IDEOM MSK-Q): an instrument to measure musculoskeletal symptoms in patients with psoriatic disease , J Invest Dermatol: 2025


Karmacharya P, Crofford LJ, Byrne DW, Stephens-Shields A, Husni ME, Scher JU, Craig E, Fitzsimmons R, Reddy SM, Magrey MN, Walsh JA, Ogdie A. Psoriatic arthritis phenotype clusters and their association with treatment response: a real-world longitudinal cohort study from the psoriatic arthritis research consortium , Ann Rheum Dis: 2025


Song WB, Michaud K, Lonowski SL, Kaufmann M, Pearson R, Del Rosso JQ, Schumacher R, Ogdie AR, Gelfand JM. The FORWARD Psoriasis Registry: Patient-Reported Outcomes in a Novel Psoriasis Registry and Comparison of Traditional, Dermatologist-Led Enrollment With Web-Based Patient Enrollment , J Psoriasis Psoriatic Arthritis: 2024


Kristensen LE, Tillett W, Nash P, Coates LC, Mease PJ, Ogdie A, Gisondi P, Ink B, Prickett AR, Bajracharya R, Taieb V, Lyris N, Lambert J, Walsh JA. Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies , Ther Adv Musculoskelet Dis, 16: 2024,1759720X241288071


Gillcrist RL, Doherty CR, Olave M, Bonilla J, England BR, Wysham K, Quinones M, Scanzello CR, Ogdie A, White DK, Neogi T, Baker JF. A Remote Behaviorally Designed Intervention to Promote Physical Activity in Patients With Knee Osteoarthritis: Results of a Pilot Randomized Clinical Trial , J Clin Rheumatol, 30: 2024,336-339


Ogdie A, Kristensen LE, Soriano ER, Akar S, Sun Y, Gruben D, Fallon L, Kinch CD, Gladman DD. Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status , Rheumatol Ther: 2024


Liew JW, Pedro S, Michaud K, Ogdie A. Opioid Use and Healthcare Utilization in Adults With Psoriatic Arthritis and Ankylosing Spondylitis , J Rheumatol, 51: 2024,1009-1014


Wright GC, Mysler E, Kwok K, Cadatal MJ, Germino R, Yndestad A, Kinch CD, Ogdie A. Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials , Rheumatol Ther: 2024